Is Enzolytics Inc. (ENZC) a Buy, Sell, or Hold?
OTC : ENZC
Enzolytics Inc.
$0.0005 USD
$0 (0.0%)
- Volume
- 3.65M
- Average Volume
- 9.03M
- Market Capitalization
- $2.42M
- P/E Ratio
- -9.34
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.63
Company Overview
OTC
Steven Sharabura
Biotechnology
Healthcare
ENZC
1
US
USD
Liquidity Metrics
-0.01
0.63
0.63
0.00
0.00
Sales & Valuation
-$
0.00
-0.01
0.00
0.00
Profitability
$0
-$92239
0.00%
0.00%
0.16%
-0.09%
P/E Metrics
-9.34
-0.05
-0.05
Analyst Price Target & Rating
1/5
0 Analysts
%
Financial Health Scores
-1.76
2/9
-$119.58M
$201.66M
$320.34M
-$367.12K
Key Metrics (TTM)
$3.41M
0.00
-22.02
0.63
0.16%
0.14%
-10.71%
0.00%
0 days
Company Executives
| Name | Title |
|---|---|
| Steven Sharabura | Chief Executive Officer |
| Diana Zhabilov | Chief Financial Officer |
| Charles S. Cotropia | President & Director |
| Harry H. Zhabilov Jr. | CSO & Chairman |
Poll Results
No votes yet today — be the first to share your view!
About Enzolytics Inc. (OTC:ENZC) Stock
Enzolytics Inc., a biopharmaceutical company based in Plano, Texas, is dedicated to the development and commercialization of its specialized protein-based therapies. Its primary focus is on addressing severe infectious illnesses. The company possesses patented anti-HIV treatments that have successfully completed clinical testing. Additionally, Enzolytics has developed a unique methodology for manufacturing human IgG1 monoclonal antibodies, intended to provide non-toxic passive immunotherapy against various infectious diseases. A significant achievement includes the creation of a proprietary cell line, specifically engineered to produce human monoclonal antibodies that effectively target and neutralize the human immunodeficiency virus (HIV). ...
Frequently Asked Questions
-
What is the current Enzolytics Inc. (ENZC) stock price?
-
Enzolytics Inc.(OTC:ENZC) stock price is $0.0005 in the last trading session. During the trading session, ENZC stock reached the peak price of $0.0013 while $0.0002 was the lowest point it dropped to. The percentage change in ENZC stock occurred in the recent session was 0.0% while the dollar amount for the price change in ENZC stock was $0.
-
ENZC's industry and sector of operation?
-
The OTC listed ENZC is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ENZC?
-
Steven Sharabura | Chief Executive Officer
Diana Zhabilov | Chief Financial Officer
Charles S. Cotropia | President & Director
Harry H. Zhabilov Jr. | CSO & Chairman
| -
How many employees does ENZC have?
-
Number of ENZC employees currently stands at 1. ENZC operates from 2000 North Central Expressway, Plano, TX 75074, US.
-
Link for ENZC official website?
-
Official Website of ENZC is: https://enzolytics.com
-
How do I contact ENZC?
-
ENZC could be contacted at phone #972 292 9414 and can also be accessed through its website. ENZC operates from 2000 North Central Expressway, Plano, TX 75074, US.
-
How many shares of ENZC are traded daily?
-
The average number of ENZC shares traded daily for last 3 months was 9.03M.
-
What is the market cap of ENZC currently?
-
The market value of ENZC currently stands at $2.42M with its latest stock price at $0.0005